Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel-Reference-Cited by-同舟云学术

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Published:2008-03 Issue:3 Volume:19 Page:420-432
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Aapro M.,Abrahamsson P.A.,Body J.J.,Coleman R.E.,Colomer R.,Costa L.,Crinò L.,Dirix L.,Gnant M.,Gralow J.,Hadji P.,Hortobagyi G.N.,Jonat W.,Lipton A.,Monnier A.,Paterson A.H.G.,Rizzoli R.,Saad F.,Thürlimann B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/3/420/681184/mdm442.pdf

Reference154 articles.

1. Development of bisphosphonates;Fleisch;Breast Cancer Res,2002

2. Use of intravenous bisphosphonates in osteoporosis;Civitelli;Curr Osteoporos Rep,2007

3. Bisphosphonates: preclinical review;Green;Oncologist,2004

4. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes;Rogers;Biochem Biophys Res Commun,1996

5. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras;Luckman;J Bone Miner Res,1998

Cited by 397 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

2. Forget Me Not: Incidental Findings on Breast MRI;Journal of Breast Imaging;2024-05-17

3. The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service;BMC Health Services Research;2024-04-02

4. Clinical practice guidelines for full‐cycle standardized management of bone health in breast cancer patients;Cancer Innovation;2024-02

5. Biomarkers and Treatment Strategies for Breast Cancer Recurrence;Current Drug Targets;2023-11